Stale Pre-tender

Supply & Maintenance of New & Maintenance of Existing Cell Selection Systems

Details

Value
£2,400,000
Topic
Human blood
Published
11 September 2024

Tender description

This Prior Information Notice (PIN) is separate to any tender opportunity. The Cellular & Molecular Therapies (CMT) laboratories within NHS Blood and Transplant ( NHSBT) provide a range of services to support haemopoietic stem cell transplantation including collection, processing, and cryopreservation of stem cells. An important part of the services offered by CMT is the purification of stem cells and depletion of other cells, such as CD3+, TCRαβ, CD19+ cells, that may cause complications in the transplant procedures. The purpose of this notice is to: • Alert potential suppliers that NHSBT intends to award a contract for the supply of consumables and maintenance of existing equipment and in addition potential purchase of new equipment & maintenance in the future if demand increases. • Develop NHSBTs understanding of the capabilities, dependencies and competitiveness of the marketplace and the ability of industry to provide the required level of support. Please express your interest by the 2nd October 2024 and direct any questions to tennille.madigan@nhsbt.nhs.uk Additional information: This Prior Information Notice (PIN) is separate to any tender opportunity. The Cellular & Molecular Therapies (CMT) laboratories within NHS Blood and Transplant ( NHSBT) provide a range of services to support haemopoietic stem cell transplantation including collection, processing, and cryopreservation of stem cells. An important part of the services offered by CMT is the purification of stem cells and depletion of other cells, such as CD3+, TCRαβ, CD19+ cells, that may cause complications in the transplant procedures. The purpose of this notice is to: • Alert potential suppliers that NHSBT intends to award a contract for the supply of consumables and maintenance of existing equipment and in addition potential purchase of new equipment & maintenance in the future if demand increases. • Develop NHSBTs understanding of the capabilities, dependencies and competitiveness of the marketplace and the ability of industry to provide the required level of support. Please express your interest by the 2nd October 2024 and direct any questions to tennille.madigan@nhsbt.nhs.uk

Timeline

  1. Completed: Pre-tender published11 September 2024
    Current notice

About the buyer

NHS Blood and Transplant runs the UK's blood and organ donation services, and buys as a national healthcare organisation with its own procurement team. Much of its buying flows through framework agreements with the Crown Commercial Service, NHS Supply Chain and NHS Shared Business Services. Four internal teams commission separately, covering Operations, Information Technology, Strategic Goods and Estates and Services.

Over the past 5 years, most of NHS Blood and Transplant's contract awards have been in medical equipment and pharmaceuticals, IT services and business services.

AI insights

  • Is there a preferred supplier?
  • What are the buyers pain points?
  • What has the buyer previously procured?
  • What are the key requirements?
Sign-up to enrich

Decision makers

Connect with the people behind this procurement.

Contact nameJob titlePhone numberWork email
Head of Procurement+44 •••• ••••••
Commercial Director+44 •••• ••••••
Procurement Manager+44 •••• ••••••
Category Lead+44 •••• ••••••
Senior Buyer+44 •••• ••••••
Contracts Manager+44 •••• ••••••

1 similar open tenders

See more open tenders related to Human blood.

Explore all open tenders

Finding public sector work shouldn't be hard

Make your next tender search effortless with Stotles. Set up alerts, find decision maker contacts and never miss a good-fit opportunity again.